drugset / Trial / NCT05344365
A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Non-randomizedSequentialOpen-labelTreatment
Summary
This is an open-label, sequential cohorts, flexible dose study to evaluate the tolerability, safety and pharmacokinetics of iloperidone in elderly patients with Parkinson's disease psychosis (PDP).
Timeline
- Start
- 2022-06
- Primary completion
- 2023-11
- Completion
- 2023-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | — | Oral |